Background: The role of preoperative serum carcinoembryonic antigen (sCEA) and postopeative tissue CEA (tCEA ) were widely elaborated separately for colorectal cancer (CRC). But the role of the combined sCEA and tCEA was scarcely described by now. Methods: 1757 cases of 0~ⅣCRC from January 2006 to January 2016 in our institution were involved. Clinicopathological features and follow up data were collected. 0 stage was combined into 0&Ⅰ stages. SCEA was classified to normal and high(>10ng/ml) and tCEA were classified into three grades (+,++,+++). So combined groups were six (2ⅹ3). ANOVA and Crosstab were used to analyze continuous and counting data, Univariate and multivariate were analyzed by Cox regression. All data were analyzed by SPSS27 and survival curves with number at risk were visualized by R 4.3.1. Results: Gender, age, tumor location, tumor size, blood loss, T stage, differentiation, harvested lymph nodes, positive lymph nodes, chemotherapy, TNM stage and complication have difference between the combined CEA test (all P

Cancer immunotherapy targeting immune checkpoints has exhibited promising clinical outcomes in many cancers, but it offers only limited benefits for pancreatic cancer (PC). Cancer stem cells (CSCs), a minor subpopulation of cancer cells, play important roles in tumor initiation, progression, and drug resistance. Accumulating evidence suggests that CSCs employ immunosuppressive effect to evade the immune recognition. However, clinical implications of the associations among CD8+ T cells infiltration, programmed death receptor ligand-1 (PD-L1) expression, and CSCs existence are poorly understood in PC. Immunostaining and quantitative analysis were performed to assess CD8+ T cells infiltration, PD-L1 expression, and their relationship with CD44+/CD133+ CSCs and disease progression in PC. CD8+ T cells infiltration was associated with better survival while PD-L1 expression was correlated with PC recurrence. Both the low CD8+ T cells infiltration/high PD-L1 expression group and the high CD8+ T cells infiltration/high PD-L1 expression group show high levels of CD44+/CD133+ CSCs, but patients with low CD8+ T cells infiltration/high PD-L1 expression had worse survival and higher recurrence risk than those with high CD8+ T cells infiltration/high PD-L1 expression. Moreover, CD8+ T cells infiltration could reduce unfavorable prognostic effect of high co-expression of PD-L1 and CD44/CD133. Our study highlights an interaction among CD8+ T cells infiltration, PD-L1 expression, and CD44+/CD133+ CSCs existence, which contributes to PC progression and immune evasion.